Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition

Aug 25, 2022 | Interviews

Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat down with CAPD spokesperson Maura Keefe to...

New PCMA Podcast Highlights Importance of Prescription Drug Rebates

Aug 16, 2022 | Press Releases

New PCMA Podcast Highlights Importance of Prescription Drug Rebates PCMA released the following press release regarding Alex Brill’s interview on the importance of prescription drug rebates. (Washington, D.C.) — The Pharmaceutical Care Management Association’s...

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded

May 12, 2022 | Analysis

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded MGA’s Alex Brill submitted a letter in response to a request for information from the Federal Trade Commission. The FTC was looking for information regarding the business practices of pharmacy benefit...

MGA Analysis of Potential Savings from Complex Generics Cited in Multiple Publications

Feb 12, 2021 | News

MGA Analysis of Potential Savings from Complex Generics Cited in Multiple Publications This week, three publications in the healthcare policy and regulatory affairs industries referenced MGA’s recent report on the potential savings from accelerating US approval...

New MGA Report on the Potential Savings from Accelerating US Approval of Complex Generics

Feb 9, 2021 | Analysis

New MGA Report on the Potential Savings from Accelerating US Approval of Complex Generics Matrix Global Advisors (MGA) today released a new report, “Potential Savings from Accelerating US Approval of Complex Generics,” by MGA founder and CEO Alex Brill....